Q1 2018 Holdings
Filed 2018-05-15 | 118 holdings | $254.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centene Corp del(CNC) | COM | 15135B101 | $62.8K | 588,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $66.9K | 2,900,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $82.7K | 794,338 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $91.1K | $99,100,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $93.4K | 755,798 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $93.9K | 6,609,894 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $97.7K | 5,227,035 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $104.9K | 2,548,111 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $124.8K | 8,621,383 | 0.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.1M | 2,602,733 | 5.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.4M | 146,000 | 6.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $21.4M | 753,322 | 8.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $25.7M | 319,920 | 10.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $29.0M | 741,016 | 11.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.9M | 366,000 | 11.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $31.6M | 482,467 | 12.4% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $35.1M | 7,366,460 | 13.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $48.1M | 2,745,705 | 18.9% |